Background and Purpose: At 7T MRI, T2*-weighted (T2*-w) gradient-echo has been shown to provide high-resolution anatomical images of gray matter (GM) lesions. However, few studies have verified T2* lesions histopathologically, or compared them with more standard techniques at ultra-high field-strength. This study aims to determine the sensitivity of T2-w and T2*-w sequences for detecting cortical GM lesions in MS.
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IntroduCtIon
Multiple sclerosis (MS) is traditionally regarded as a chronic inflammatory demyelinating disease of the white matter (WM) with a variable clinical course; primary progressive or relapsingremitting with possible conversion to secondary progressive. Pathological, immunological and imaging studies have confirmed that tissue damage in the gray matter (GM) is also a key component of the disease process [1] [2] [3] [4] , GM pathology occurs frequently, already early on in the disease course, and explains cognitive and clinical disability better than white matter (WM) lesions 5, 6 . Nevertheless, visualizing these GM abnormalities has been challenging due to their small size, absence of inflammation and partial volume effect from adjacent cerebrospinal fluid (CSF) and WM. The introduction of (ultra-)high field MRI scanners and specific MRI pulse sequences have improved the detection of GM lesions due to a higher signal-to-noise ratio and better spatial resolution [7] [8] [9] . 7T T2*-weighted gradient-echo MRI has been shown to provide high-resolution anatomical images of GM lesions and it has even been suggested that this sequence be used as the new gold standard for GM lesion detection 10 . It was reported to be 44% more sensitive than 1.5T MRI in detecting lesions with cortical involvement 11 and up to 69% more sensitive than 3T Double Inversion Recovery (DIR) imaging in detecting subpial lesions 10 . Few groups have had the opportunity to study GM lesions that were visualized with 7T T2* in terms of histopathology. Therefore, little information is available on the exact sensitivity of T2* and/or whether certain lesion types are better visible than others with this sequence. One postmortem study that did look at T2* sensitivity showed a 48% prospective sensitivity, but made no distinction between lesion types 12 . Another 7T study found that 46% of cortical lesions could be prospectively detected using T2*, and a similar 43% could be detected using a WM-attenuated turbo field echo (WHAT-TFE) 13 . However, the two sequences studied were suboptimally matched in terms of image resolution, which may explain the relative absence of differences between them. The current study aims to determine the sensitivity of a standard T2-w and a T2*-w sequence, using the same image resolution, for detecting MS GM lesion types in postmortem MS tissue.
MaterIals and Methods
Patients and Postmortem Examination
Coronally cut, 10-mm thick full-hemispheric brain slices of 15 patients with histopathologically confirmed MS (7 female) were selected after rapid autopsy (mean postmortem delay 5 hours 56 minutes) and were formalin-fixed. Additionally, 12 control slices from 4 donors were obtained (recruited and evaluated by the Pathology department of Pathology of the VU University medical center (Amsterdam, The Netherlands)). Table 1 provides demographic and neuropathological details of the donors. Prior to death, all donors were registered at the Netherlands Brain Bank, Amsterdam, the Netherlands. All donors gave written informed consent for the use of their tissue and medical records for research purposes. Permission for performing autopsies, use of tissue and access to medical records, was granted by the institutional ethics review board.
MR Imaging
Imaging was performed using a 7.0 Tesla Bruker Biospec USR70/30 imager (Bruker BioSpin MRI GmbH, Ettlingen, Germany) and a vendor provided 8.6 cm diameter RF transmit/receive coil (model 1P T12053V3). Each formalin-fixed brain slice was placed into a rectangular plastic tissue container and immersed in 10% buffered formalin. Particular care was devoted to sequence optimization due to the effect of tissue fixation on sequence parameters. The MRI protocol included a 2D multi-echo spin-echo (SE) T2-weighted (TR/TE1/TE2/TE3: 4000/19.1/38.2/57.3ms; α: 90 and 180; averages: 6) and a 3D gradient echo (GRE) T2*-weighted (TR/TE: 25/12 ms; α: 5; averages: 16) sequence. All MRI sequences were acquired with a FOV of 100 x 80, Matrix of 1000 x 800 and in-plane spatial resolution of 100μm x100μm with slice thickness 1mm.
Contrast-to-noise ratios (CNR) were determined for the different MR image types in the MS samples, on the basis of signal intensity (SI) measurements in regions-of-interest (i.e., NAGM, GM lesions, NAWM, WM lesions, formalin [noise] ). The CNR between two tissue types was defined as: |SI1 -SI2|/standard deviation (noise). For T2-w images, the TE of 19.1 ms was used for lesion detection and CNR calculation.
Histology
After MRI, the brain slices were cut in half to reveal the imaged plane, and embedded in paraffin. 8-um-thick sections were cut, mounted onto glass slides (Superfrost, VWR international, Leuven, Belgium) and dried overnight at 37 o C. Sections were deparaffinized in a series of xylene, 100% alcohol (ethanol), 96% alcohol, and 70% alcohol and rinsed with 0.01 mol/L tris-buffered saline (TBS, pH 7.8-8.0). Endogenous peroxidase activity was blocked by incubating the sections in TBS with 0.3% H 2 O 2 for 30 minutes. After this, the sections were rinsed with 0.01 mol/L phosphatebuffered saline (PBS, pH 7.4). Staining was performed with antibodies against proteolipid protein (PLP; Serotec, Oxford, UK) diluted in TBS (1:500) containing 1% normal goat serum (NGS; DAKO, Glostrup, Denmark) and stored overnight at 6 o C. Immunolabeling was detected by incubating the sections in biotinylated goat anti-mouse (1:400; Vector Laboratories, Burlingame, CA) and in Vectastain avidin-biotinperoxidase complex (ABC-HRP; 1:200; Vector Laboratories, Burlingame, CA) for 60 min at room temperature. Afterwards, the sections were washed in 0.05M tris-HCL (pH 7.6). Peroxidase activity was demonstrated with 0.5 mg/mL 3,3′ diaminobenzidine tetrahydrochloride (DAB; Sigma, St. Louis, MO) in 0.01 mol/L tris-hydrochloride containing 0.03% H 2 O 2 for 5 minutes, which led to a brown reaction product. Sections were counterstained with hematoxylin (Sigma, St. Louis, MO) and mounted (Depex, BDH; Poole, UK).
Scoring, Classification and Matching
MR lesions were manually marked on all T2*-w MR images and all T2-w MR images with TE = 19.1, which had similar contrast to clinically used T2-w sequences. The Medical Image Processing, Analysis and Visualization (MIPAV, Centre for Information Technology, National Institutes of Health, Bethesda, MD, USA) application was used for manual prospective and retrospective lesion scoring. The MRI reader's scoring was blinded to clinical information and histopathological results. Lesions were scored throughout all of the MR slices in order to avoid 2 CHAPTER No, number of hemispheric slices included per case; PMD, post-mortem delay (h:min), control cases are not part of the rapid autopsy program and have therefore a longer PMD; DD, disease duration in years since diagnosis; SPMS, secondary progressive multiple sclerosis; PPMS, primary progressive multiple sclerosis; COD, cause of death; n/a, unavailable/unknown.
bias towards scoring within the sampled areas. A subset of images (n=5 for each sequence) were rated by a second independent reader to ascertain quality of scoring and calculate an Intraclass Correlation Coefficient (ICC) for each sequence.
Histopathologically, lesions were defined as areas of complete demyelination (lack of PLP) and were scored by a histopathological reader, blinded to the clinical and MRI data. GM lesions were scored and classified according to criteria described in Bo et al 14 where a distinction between four cortical lesion types is made; Type I lesions involve the deeper layers of the GM as well as the adjacent WM; Type II lesions are small demyelinated lesions, often centered around blood vessels and confined within the cortex; Type III lesions extend from the pial surface into the cortex, most often reaching to cortical layers 3 or 4. When these lesions involve the entire span of the cortex without entering the subcortical white matter, they were defined as type IV lesions. After MRI and histopathology scoring, hemispheric tissue sections were matched to the corresponding MRI planes using WM lesions and as many cortical anatomical landmarks as possible. After the blinded prospective scoring of the postmortem MRI and the tissue-to-MRI matching, histopathology scores were made available to the MRI readers and a second, retrospective, unblinded scoring was performed in consensus between raters.
Analysis of Data
Histopathological lesion count was considered the standard criterion. Therefore, prospective and retrospective sensitivity of MRI sequences for detecting lesions was determined by dividing the number of lesions scored in the prospective or retrospective ratings by the number of lesions assessed on histopathology, times 100%. Sensitivity of T2-w and T2*-w MR sequences was statistically compared using the Wilcoxon signed-rank test in SPSS 20.0 (SPSS, Inc., Chicago, IL). Specificity of MRI sequences was determined by dividing the number of false positives by the number of lesions assed on histopathology and subtracting this number from 100%. The interrater agreement for prospective lesion detection was expressed as an ICC for each sequence (T2-w and T2*-w) by using a two-way random effects model in absolute agreement. Due to the small number of WM lesions, differences in WM CNRs were kept descriptive. For the difference between GM and GML and between GM and WM (both normally distributed), a paired sampled t-test was done.
results
Of the MRI scanned and histopathologically processed samples, one slice from one patient did not show any histopathological abnormalities and was therefore excluded from analysis. The control slices did not show, apart from age related frontal capping, any histopathological abnormalities. This resulted in a final dataset of 26 brain slices (from 14 patients and 4 controls). In the MS brain slices we identified a total of 105 lesions on MRI that were verified by histopathology; 7 lesions of the WM and 98 cortical lesions. Of these cortical lesions, 14 were mixed GM-WM (type I) lesions and 84 were located entirely within the cortical GM (16 type II lesions, 43 type III lesions and 25 type IV lesions). The ICC for the T2-w sequence was 0.972, the ICC for the T2*-w sequence was 0.968. 
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Comparison of Lesion Scoring between T2-w and T2*-w Imaging
Results of histopathological count and the proportion of lesions detected prospectively and retrospectively on T2-w and T2*-w sequences are shown in table 2. When focusing on cortical GM lesions (I-IV), the T2-w sequence detected 69% more lesions than T2*-w (table 2) . This difference in GM I-IV lesion detection was not significant (p = 0.054). When only focusing on intracortical GM lesions (II-IV), the T2-w sequence detected 36% more lesions than T2*-w sequence. This difference was also not significant (p = 0.38). Upon retrospective scoring, when lesion location was revealed to the MR reader, a total of 81 and 82 cortical lesions were found with the T2-w sequence and T2*-w sequence respectively, an increase of 200% and 413% compared to prospective scoring. Figure 1 shows a matched histological, T2-w and T2*-w images with prospectively and retrospectively detected lesions. Further to the detected lesions, we scored a total of 19 false positives (marked on MRI as a lesion but not confirmed by histopathology); 9 on the T2-w sequence and 10 on the T2*-w sequence. This results in a specificity of 91.4% for the T2-w and 90.5% for T2-w sequence. Upon microscopic inspection of these false positives, it appeared that many of the cases (89% for T2-w and 80% for the T2*-w sequence), were incompletely demyelinated/remyelinated lesions, which were not scored as they did not fulfill the criterium of a 'fully demyelinated lesion' (see Methods).
Contrast to noise ratios for the various tissue types are shown in table 3. Although only descriptive, the T2-w images show higher WM-WML CNR, which could account for the higher prospective sensitivity than T2*-w images (see table 2 ). Regarding the T2-w and T2*-w images, a paired sample t-test showed no significant difference between the comparably low GM-GML CNRs. WM-WML white matter to white matter lesion CNR; GM-GML gray matter to gray matter lesion CNR, also divided in prospectively and retrospectively found lesions; GM-WM gray matter to white matter CNR.
CHAPTER dIsCussIon
In the current study, we have demonstrated that prospectively, i.e. without knowledge about histopathology (location and type of lesions), the standard T2-w sequence detected more cortical lesions than the T2*-w sequence (i.e. 28% versus 16%, respectively), although this difference was not statistically significant. When only intracortical lesions were taken into account this difference between sequences vanished completely. This difference between sequences also vanished when lesion location was revealed to the reader (retrospective scoring). An explanation for this slight prospective difference could be that the T2*-w sequence is more susceptible to global inhomogeneities such as tissue-toformalin boundaries, leading to local T2* signal decay 15 , which could hinder prospective lesion detection.
Retrospective detection of cortical lesions increased to 83% for the T2-w and 84% for the T2*-w sequence. Focusing on intracortical lesions, retrospective detection increased to 80% and 82% respectively. This retrospective detection sensitivity is much higher than in previous post mortem MRI studies at lower field strength. Previous studies at 1.5T detected only 31% 3 or 56% 16 of intracortical lesions with a T2-w sequence and 29% with a DIR sequence 17 . With a FLAIR sequence, 9% 17 , 21% 3 or 71% 18 of intracortical lesions were detected retrospectively. Compared to previous postmortem MRI studies at Ultra High Field (7T) strength, our T2-w and T2*-w retrospective detection rates are higher than the 67% found with R2* maps 19 , comparable to the 82% found with WHAT-TFE, and slightly lower than the 93% detected with T2*-w 13 . However, prospective lesion detection in these studies varies between 42% -48% 13,19, , which is higher than our cortical detection rate of up to 28%. One explanation for this higher detection rate in other studies could be the type of lesions identified; the majority of lesions found by Yao et al. were the more easily detectable type I lesions 19 , while the majority of lesions in our sample were the more difficult to detect type III lesions. Another explanation could be the higher CNR as found in the study by Pitt et al. Their T2*-w sequence had a GML-GM CNR of 3.4 while our study only had an average CNR of 1.7, making distinction between GML and surrounding GM more difficult. These differences could have led to a more optimal sequence for lesion detection by Pitt et al 13 . Future studies will need to be carried out to see how lesion heterogeneity and within sequence differences influences lesion detection. As shown by the high retrospective lesion count, 7T MRI has greatly improved the possibility of detecting (intra)cortical lesions. However, the challenge remains to actually detect them prospectively and in vivo.
Regardless of 7T MRI, with increased signal to noise ratio and spatial resolution, the number of prospectively detected cortical lesions on MR images remains low; in our study up to 84% of (intra)cortical lesions go undetected. In another study at 7T, up to 57% of cortical lesions are still missed 13 . Lesion size has been found to affect visibility of cortical lesions at both 1.5T 20 and 7T 13 . Furthermore, extensive cortical demyelination could hinder visibility of type IV lesions; when most of the cortex is affected there is no NAGM present, making it is difficult to differentiate between areas of demyelination and NAGM (see figure 2) . Perhaps quantitative MRI could provide additional information in these areas 21 . Automated segmentation could be another option to aid cortical lesion detection, although this could be extremely challenging due to a lack of contrast in the cortex, especially in the upper layers where most cortical lesions are located. Nevertheless, retrospective lesion detection shows that it is possible to find cortical lesions on MRI when lesion location is (histopathologically) known, indicating that observer training is important, and could dramatically increase future prospective sensitivity.
There were only seven WML observed during histopathological analysis. This seems low, but the coronal slices were sampled from more frontal regions of the brain, a preferential area for cortical pathology 22, 23 , but less so for WML which are more frequently located periventricular.
Sequence parameters were optimized for the effect of fixation, SNR and spatial resolution. Fixed tissue suffers from a decrease in T2 signal 24 which leads to lower contrast and requires an increase in averages to achieve a reasonable SNR. This results in an increase in acquisition time, a methodological limitation when trying to compare the results from this study to the in vivo setting. The sequences used can be optimized for the 7T in vivo setting, but identifying cortical lesions will remain especially challenging for smaller sized lesion 20 . Another limitation in correlative studies between histopathology and MRI is matching tissue sections to MR images. Tissue sections were 8 µm whilst MR images had a slice thickness of 1mm. However, accurate matching was made possible due to the many anatomical landmarks in the full-hemispheric slices used in this study.
FIgure 2 | Example of extensive cortical demyelination in an MS case. Histological section with anti-PLP antibody (left) and matched T2-w image (right). CC= corpus callosum. The histological section shows extensive cortical demyelination (lack of PLP) in the cortex, except for a small section at the left bottom (see *). This extensive demyelination makes it difficult to differentiate between lesion and NAGM on MRI (right). In this particular case, as a result, prospective MRI scoring was negative.
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Taking a look at the in vivo setting, DIR is reported to improve cortical lesion detection at 3T compared to 1.5T, while T2-w or FLAIR are not 25 . In turn, a 75% increase in cortical lesion detection was found with 7T T2-w versus 3T T2-w. For T1 and FLAIR this was even 91% and 238% respectively 26 . Another study found a 65% increase in cortical lesion detection with 7T T2* versus 3T DIR 10 . The same research group also investigated how various lesion types contributed to physical and cognitive performance. They found that type III-IV lesions had the strongest relationship to physical disability. In turn, type I lesions, and in a lesser extent type III-IV lesions, had a relationship with cognitive performance 27 . At 3T, DIR detected 538% more intracortical lesions than T2-w and 152% more intracortical lesions than FLAIR 18 . This was supported by another study in which DIR detected 43% more cortical lesions than FLAIR 9 . However, a study from Kilsdonk et al 28 at ultra high-field strength (7T), showed that FLAIR detected 89% more cortical lesions than DIR, and that DIR and T2-w obtained nearly identical mean cortical lesion counts (115 vs 116). This indicates that a sequence that may be optimal at lower field strength (DIR at 3T), may lose its benefit at higher field strength (7T), and vice versa: a sequence suboptimal at lower field strength may gain benefit over other sequences at higher field strength (FLAIR or T2* at 7T). It would be useful if future studies could elucidate which sequences have optimal lesion detection at which field strength. PSIR looks promising at 3T with a 307% increase over DIR 29 , but how does it hold at 7T? How do FLAIR, T2 and T2* hold against each other at 7T in one comparative study?
ConClusIon
Our findings suggest that at 7T, a T2-w and T2*-w sequence are equally capable in detecting up to 83-84% of cortical lesions in post mortem MS samples. However, many lesions are still missed prospectively. With observer training the expectation is that not only the 'tip' but a large part of the proverbial 'iceberg' of GM lesions may be uncovered. 
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